The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals
Abstract
This article provides an overview of the patient‐specific and drug‐specific variables that can affect drug absorption following oral product administration. The oral absorption of any chemical entity reflects a complex spectrum of events. Factors influencing product bioavailability include drug solubility, permeability, and the rate of in vivo dissolution. In this regard, the Biopharmaceutics Classification System has proven to be an important tool for predicting compounds likely to be associated with bioavailability problems. It also helps in identifying those factors that may alter the rate and extent of drug absorption. Product bioavailability can also be markedly influenced by patient attributes such as the integrity of the gastrointestinal tract, physiological status, site of drug absorption, membrane transporters, presystemic drug metabolism (intrinsic variables), and extrinsic variables such as the effect of food or concomitant medication. Through an awareness of a drug's physicochemical properties and the physiological processes affecting drug absorption, the skilled pharmaceutical scientist can develop formulations that will maximize product availability. By appreciating the potential impact of patient physiological status, phenotype, age, gender, and lifestyle, dosing regimens can be tailored to better meet the needs of the individual patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral drug delivery is the most preferred and convenient route for drug administration and can be utilised for both systemic or local drug delivery.17”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [17]
In the citing paper
“Nevertheless, oral drug delivery till today faces several challenges like poor drug solubility, stability, and permeability.”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Self-citationStudies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones
Adlercreutz, H., Pulkkinen, M. O., Hämäläinen, E. K., & Korpela, J. T. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90208-5 · Cited by 151
Research works printed but not linked: 146
- 10.1016/S0168-3659(99)00050-4 · DOI
- 10.1023/A:1018879014281 · DOI
- 10.1016/S0939-6411(00)00091-6 · DOI
- 10.1016/0163-7258(81)90040-1 · DOI
- 10.1023/A:1018880726035 · DOI
- 10.2165/00003088-199936030-00004 · DOI
- Sokoloski TD, 1985, Remington's Pharmaceutical Sciences., 207
- 10.1023/A:1018816122458 · DOI
- 10.1016/S0939-6411(99)00055-7 · DOI
- 10.1023/A:1007556711109 · DOI
- 10.1016/S0304-4157(97)00008-7 · DOI
- 10.1021/js950285r · DOI
- 10.1023/A:1011948703571 · DOI
- 10.1016/S0168-3659(99)00239-4 · DOI
- 10.1023/A:1016093704095 · DOI
- Palm K, 1999, Effect of molecular charge on intestinal epithelial drug transport, J Pharmacol Exp Therap, 291, 435
- 10.1023/A:1016220428705 · DOI
- Jackson MJ, 1987, Physiology of the Gastrointestinal Tract
- 10.1021/js970120d · DOI
- 10.1016/0169-409X(96)00009-9 · DOI
- 10.1023/A:1011910517200 · DOI
- 10.1023/A:1011958400362 · DOI
- Abdou HM, 1989, Dissolution, Bioavailability and Bioequivalence.
- 10.1023/A:1007596709657 · DOI
- Cussler EL, 1997, Diffusion: Mass Transfer in Fluid Systems.
- 10.1023/A:1018911728161 · DOI
- 10.1023/A:1016010207729 · DOI
- 10.1023/A:1018832526093 · DOI
- 10.1023/A:1015936426906 · DOI
- Dressman JB, 1997, Scientific Foundations for Regulating Drug Product Quality., 155
- 10.3109/10837459709022605 · DOI
- 10.3109/10837459809028636 · DOI
- 10.3109/10837459809028625 · DOI
- 10.1016/S0168-3659(99)00022-X · DOI
- Lin JH, 1999, Is the role of the small intestine in first‐pass metabolism overemphasized, Pharmacological Rev, 51, 135
- Lin JH, 1998, Applications and limitations of interspecies scaling and in‐vitro extrapolation in pharmacokinetics, Drug Metab Disp, 26, 1202
- Yeh KE, 1998, Single‐dose pharmacokinetics of indinavir and the effect of food, Antimicrob Agents Chemother, 42, 332, 10.1128/AAC.42.2.332 · DOI
- 10.1023/A:1018872207437 · DOI
- Lin JH, 1999, Effect of dexamethasone on the intestinal first‐pass metabolism of indinavir in rats: evidence of cytochrome P‐450 A and P‐glycoprotein induction, Drug Metab Disp, 27, 1187
- 10.1016/0163-7258(90)90036-2 · DOI
- 10.2165/00003088-199426020-00007 · DOI
- 10.3109/10408449209089881 · DOI
- 10.1016/S0009-9236(96)90162-9b · DOI
- 10.1128/AAC.38.4.842 · DOI
- 10.1016/0009-9236(95)90032-2 · DOI
- 10.1016/S0168-3659(99)00034-6 · DOI
- 10.1021/js980082d · DOI
- Davis LE, 1972, Pharmacokinetics of chloramphenicol in domesticated animals, Am J Vet Res, 33, 2259
- 10.1002/jps.2600810105 · DOI
- 10.1208/ps020104 · DOI
- Morgan ET, 1998, Physiological and pathophysiological regulation of cytochrome P450, Drug Metab Disp, 26, 1232
- Devane J, 1998, Oral drug delivery technology: addressing the solubility/ permeability paradigm, Pharm Tech, 22, 68
- 10.1016/S0928-0987(99)00076-7 · DOI
- 10.1007/978-1-4684-6036-0_17 · DOI
- 10.1002/jps.2600841205 · DOI
- 10.1023/A:1018918907670 · DOI
- 10.1016/0731-7085(91)80060-M · DOI
- 10.1038/bjc.1992.217 · DOI
- 10.1007/s002800050451 · DOI
- Monkhouse DC, 1972, Drug‐excipient interactions, Can J Pharm Sci, 7, 29
- 10.1016/S0378-5173(99)00176-3 · DOI
- 10.1016/S0014-827X(98)00101-3 · DOI
- 10.1023/A:1016203424278 · DOI
- 10.1016/0016-5085(90)91150-5 · DOI
- 10.1007/BF01079784 · DOI
- 10.1113/jphysiol.1975.sp010891 · DOI
- 10.1016/0016-5085(85)90589-X · DOI
- Welling PG, 1985, Effect of food on bioavailability of drugs, Pharm Int, 1, 14
- 10.1016/S0928-0987(99)00041-X · DOI
- 10.1053/gast.2000.18148 · DOI
- 10.1016/0016-5085(95)23757-7 · DOI
- 10.1016/0016-5085(91)70007-K · DOI
- 10.1023/A:1011962501270 · DOI
- 10.1016/S0169-409X(97)00040-9 · DOI
- 10.1007/BF02336686 · DOI
- 10.1002/jps.2600671110 · DOI
- 10.1023/A:1018918316253 · DOI
- 10.1128/AAC.39.8.1671 · DOI
- 10.1023/A:1018982409661 · DOI
- 10.1136/gut.44.4.483 · DOI
- 10.1023/A:1018874913372 · DOI
- 10.1023/A:1012183313218 · DOI
- 10.1023/A:1016211015926 · DOI
- 10.1016/S0005-2736(99)00167-4 · DOI
- 10.1016/S0928-0987(00)00163-9 · DOI
- 10.1080/00498250110060969 · DOI
- 10.1208/ps020320 · DOI
- 10.1023/A:1018982505021 · DOI
- Oh D‐M, 1999, Membrane Transporters as Drug Targets, 59
- Iseki K, 1999, Multiplicity of the H+‐dependent transport mechanism of dipeptide and anionicbeta‐lactam antibiotic ceftibuten in rat intestinal brush‐border membrane, J Pharmacol Exp Ther, 289, 66
- 10.1007/978-1-4613-1143-0_27 · DOI
- Saitoh H, 1996, The secretory intestinal transport of some beta‐lactams antibiotics and anionic compounds: a mechanism contributing to poor drug absorption, J Pharmacol Exp Ther, 278, 205
- 10.1016/S0928-0987(00)00178-0 · DOI
- 10.1016/S0169-409X(01)00183-1 · DOI
- 10.1042/bj2990253 · DOI
- 10.1006/bbrc.1996.0082 · DOI
- 10.1016/S0378-5173(00)00564-0 · DOI
- 10.1006/abbi.2000.2084 · DOI
- 10.1016/S0022-5193(88)80123-1 · DOI
- Berlioz F, 1999, Neural modulation of cephalexin intestinal absorption through the di‐ and tripeptide brush border transporter of rat jejunum in vivo, J Pharmacol Exp Ther, 288, 1037
- Berlioz F, 2000, Alpha(2)‐adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line, J Pharmacol Exp Ther, 294, 466
- Schwiebert EM, 1994, Heterotrimeric G proteins, vesicle trafficking, and CFTR Cl 2 channels, Am J Physiol, 267, C272, 10.1152/ajpcell.1994.267.1.C272 · DOI
- 10.1074/jbc.273.35.22627 · DOI
- Paris H, 1990, Alpha2‐adrenoreceptor in rat jejunum epithelial cells: characterization with [3 H]RX821002 and distribution along the villus‐crypt axis, J Pharmacol Exp Ther, 254, 888
- 10.1172/JCI116427 · DOI · Paper page
- 10.1006/bbrc.1996.0493 · DOI
- 10.1172/JCI117908 · DOI
- 10.1126/science.1065588 · DOI
- 10.1016/S0304-3835(00)00646-7 · DOI
- 10.1023/A:1011971303880 · DOI
- 10.1023/A:1011959828103 · DOI
- 10.1016/S0168-3659(99)00034-6 · DOI
- Dresser MJ, The MDR1, C3435T polymorphism: effects on P‐glycoprotein expression/function and clinical consequences, AAPS PharmSci, 3
- 10.1023/A:1012113430539 · DOI
- 10.1016/S0169-409X(97)00041-0 · DOI
- 10.1111/j.1476-5381.1996.tb15612.x · DOI
- 10.1093/emboj/20.20.5615 · DOI
- 10.1124/mol.58.3.624 · DOI
- 10.1023/A:1016217505990 · DOI
- 10.1016/S0928-0987(00)00177-9 · DOI
- 10.1016/S0169-409X(01)00178-8 · DOI
- 10.1172/JCI119439 · DOI
- 10.1002/bdd.2510160505 · DOI
- 10.2165/00003495-199141060-00009 · DOI
- Gottesman MM, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu Rev Biochem, 62, 386, 10.1146/annurev.bi.62.070193.002125 · DOI
- 10.1006/abbi.1995.1298 · DOI
- 10.1016/S0006-2952(97)00436-X · DOI
- 10.1073/pnas.94.5.2031 · DOI
- 10.1073/pnas.97.7.3473 · DOI
- 10.1016/S0006-2952(99)00377-9 · DOI
- 10.1016/S0304-3835(99)00355-9 · DOI
- Woodcock DM, 1990, Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water‐insoluble vitamins and drugs, Cancer Res, 50, 4199
- 10.1016/S0009-9236(96)80007-5 · DOI
- Squier TC, 1988, Lipid fluidity directly modulates the overall protein rotational mobility of the Ca‐ATPase in sarcoplamsic reticulum, J Biol Chem, 263, 9178, 10.1016/S0021-9258(19)76523-5 · DOI
- 10.5414/CPP38196 · DOI
- 10.1046/j.1432-1327.1999.00037.x · DOI
- 10.1016/S0959-8049(00)00450-0 · DOI
- 10.1007/s002100000335 · DOI
- Phan CT, 2001, Intestinal lipid absorption and transport, Front Biosci, 6, 299, 10.2741/Phan · DOI
- 10.1152/ajpendo.2001.281.5.E916 · DOI
- Chow SL, 1979, A dual, concentration‐dependent absorption mechanism of linoleic acid by rat jejunum in vitro, J Lipid Res, 20, 349, 10.1016/S0022-2275(20)40617-0 · DOI
- 10.1016/S0169-409X(01)00181-8 · DOI
- 10.1016/S1043-2760(01)00433-7 · DOI
- 10.1021/bi00460a026 · DOI
- 10.1016/S0021-9150(00)00456-1 · DOI
- 10.1126/science.290.5497.1771 · DOI
Cited by
Sorted by citations
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Processing of collagen based biomaterials and the resulting materials properties
Meyer, M. (2019) · BioMedical Engineering OnLine · doi:10.1186/s12938-019-0647-0 · Cited by 539
Dahan, A., Miller, J. M., Hoffman, A., Amidon, G. E., & Amidon, G. L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22033 · Cited by 224
Self-citationMiller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200181v · Cited by 204
Self-citationEnteric coating of oral solid dosage forms as a tool to improve drug bioavailability
Maderuelo, C., Lanao, J. M., & Zarzuelo, A. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105019 · Cited by 147
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Bhattacharya, I., Tarabar, S., Liang, Y., Pradhan, V., Owens, J., & Oemar, B. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.025 · Cited by 30
Metadata
- Authors
- Martinez, M. N., & Amidon, G. L.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 42
- Issue
- 6
- Pages
- 620-643
- ISSN
- 0091-2700
- 1552-4604
- Cited by
- 536
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review